Reconciling Intellectual Property Rights and Medication Costs
August 4, 2011 · Posted in Uncategorized · Comments Off
This reconciliation all boils down to one simple fact. Many third world countries are unable to provide decent medical care due to pharmaceutical companies who are refusing to license their intellectual property, i.e. medications, to companies at affordable prices.
Trade negotiations seem to falter between major distribution areas, such as the United States, Switzerland, Germany, and Japan, to wave their intellectual property rights. If they were to do so, smaller nations could develop more generic brands of medications for cheaper Read more